Literature DB >> 31586642

Clinical applications of nanomedicine in cancer therapy.

Mohammad Norouzi1, Mehrnaz Amerian2, Mahshid Amerian2, Fatemeh Atyabi3.   

Abstract

One step forward to treat advanced and metastatic cancers: how cancer nanomedicine improves patient survival and clinical outcome while reducing systemic adverse effects of conventional treatments.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2019        PMID： 31586642     DOI： 10.1016/j.drudis.2019.09.017

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


  15 in total

1.  Effect of Lonicerae japonicae Flos Carbonisata-Derived Carbon Dots on Rat Models of Fever and Hypothermia Induced by Lipopolysaccharide.

Authors:  Jiashu Wu; Meiling Zhang; Jinjun Cheng; Yue Zhang; Juan Luo; Yuhan Liu; Hui Kong; Huihua Qu; Yan Zhao
Journal:  Int J Nanomedicine       Date:  2020-06-12

2.  Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.

Authors:  Mohammad Norouzi; Vinith Yathindranath; James A Thliveris; Brian M Kopec; Teruna J Siahaan; Donald W Miller
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

Review 3.  Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine.

Authors:  Ninh M La-Beck; Md Rakibul Islam; Maciej M Markiewski
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

4.  Creative Approaches to Global Cancer Research and Control.

Authors:  Anne F Rositch; Christopher Loffredo; Maria T Bourlon; Paul C Pearlman; Clement Adebamowo
Journal:  JCO Glob Oncol       Date:  2020-07

Review 5.  Engineering of bioactive metal sulfide nanomaterials for cancer therapy.

Authors:  Weidong Fei; Meng Zhang; Xiaoyu Fan; Yiqing Ye; Mengdan Zhao; Caihong Zheng; Yangyang Li; Xiaoling Zheng
Journal:  J Nanobiotechnology       Date:  2021-03-31       Impact factor: 10.435

Review 6.  Supramolecular lipid nanoparticles as delivery carriers for non-invasive cancer theranostics.

Authors:  Syeda Zunaira Bukhari; Kornelius Zeth; Maryam Iftikhar; Mubashar Rehman; Muhammad Usman Munir; Waheed S Khan; Ayesha Ihsan
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-10-28

7.  Nucleoside transporter-guided cytarabine-conjugated liposomes for intracellular methotrexate delivery and cooperative choriocarcinoma therapy.

Authors:  Weidong Fei; Yunchun Zhao; Xiaodong Wu; Dongli Sun; Yao Yao; Fengmei Wang; Meng Zhang; Chaoqun Li; Jiale Qin; Caihong Zheng
Journal:  J Nanobiotechnology       Date:  2021-06-15       Impact factor: 10.435

Review 8.  An Updated Overview on Nanonutraceuticals: Focus on Nanoprebiotics and Nanoprobiotics.

Authors:  Alessandra Durazzo; Amirhossein Nazhand; Massimo Lucarini; Atanas G Atanasov; Eliana B Souto; Ettore Novellino; Raffaele Capasso; Antonello Santini
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

Review 9.  Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid.

Authors:  Jingwei Shao; Yifan Fang; Ruirui Zhao; Fangmin Chen; Mingyue Yang; Jiali Jiang; Zixuan Chen; Xiaotian Yuan; Lee Jia
Journal:  Asian J Pharm Sci       Date:  2020-03-21       Impact factor: 6.598

10.  Fabrication of CaCO3-Coated Vesicles by Biomineralization and Their Application as Carriers of Drug Delivery Systems.

Authors:  Chiho Miyamaru; Mao Koide; Nana Kato; Shogo Matsubara; Masahiro Higuchi
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.